Patents by Inventor Zain Yousaf

Zain Yousaf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BTK INHIBITORS
    Publication number: 20250034150
    Abstract: Provided are compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein the variables in Formula (I) are as defined herein; and methods for their use and production.
    Type: Application
    Filed: November 10, 2022
    Publication date: January 30, 2025
    Inventors: Brian T. Hopkins, Bin Ma, Jürgen Schulz, Marta Nevalainen, TeYu Chen, Robin Prince, Harold George Vandeveer, Isaac Marx, Simone Sciabola, Zain Yousaf
  • BTK INHIBITORS
    Publication number: 20240327380
    Abstract: Provided are compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R7, R8, R9, A1, A2, Q1, Q2, Q3, A, Z, m and n are as defined herein; pharmaceutical compositions comprising said compounds or pharmaceutically acceptable salts thereof, and pharmaceutically acceptable excipients; and methods of treating a disorder responsive to inhibition of Bruton's tyrosine kinase using said compounds, or pharmaceutically acceptable salts thereof, or said pharmaceutical compositions.
    Type: Application
    Filed: August 5, 2021
    Publication date: October 3, 2024
    Applicant: BIOGEN MA INC.
    Inventors: Brian T. Hopkins, Isaac Marx, Jürgen Schulz, Harold George Vandeveer, Robin Prince, Marta Nevalainen, TeYu Chen, Zain Yousaf, Martin Himmelbauer, Vatee Pattaropong, John Howard Jones, Rab Gilfillan, Edward Yin Shiang Lin, Felix Gonzalez Lopez de Turiso, Bin Ma
  • PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS
    Publication number: 20240083900
    Abstract: Provided are compounds of Formula (I?): or pharmaceutically acceptable salts thereof, wherein the variables in the formula are as defined herein; and methods for their use and production.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 14, 2024
    Applicant: BIOGEN MA INC.
    Inventors: Brian T. Hopkins, Bin Ma, Isaac Marx, Jürgen Schulz, George Vandeveer, Robin Prince, Marta Nevalainen, TeYu Chen, Zain Yousaf, Martin Himmelbauer, Vatee Pattaropong, John Howard Jones, Edward Yin-Shiang Lin, Felix Gonzalez Lopez de Turiso, Thomas Purgett, Andrew George Capacci, Simone Sciabola
  • BTK INHIBITORS
    Publication number: 20230121818
    Abstract: Provided are compounds of Formula (I?) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R8, R9, R11A, R11B, R12, Ri, Rii, A1, A2, Q1, Q2, Q3, X, W, and n are as defined herein; pharmaceutical compositions comprising said compounds or pharmaceutically acceptable salts thereof, and pharmaceutically acceptable excipients; and methods of treating a disorder responsive to inhibition of Bruton's tyrosine kinase using said compounds, or pharmaceutically acceptable salts thereof, or said pharmaceutical compositions.
    Type: Application
    Filed: December 23, 2020
    Publication date: April 20, 2023
    Inventors: Bin Ma, Brian T. Hopkins, Isaac Marx, Jürgen Schulz, George Vandeveer, Robin Prince, Marta Nevalainen, TeYu Chen, Zain Yousaf, Andrew George Capacci